* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the -threonine
Gene desert wikipedia , lookup
Signal transduction wikipedia , lookup
Biochemistry wikipedia , lookup
Point mutation wikipedia , lookup
Gene expression wikipedia , lookup
Genetic code wikipedia , lookup
Endogenous retrovirus wikipedia , lookup
Paracrine signalling wikipedia , lookup
Genetic engineering wikipedia , lookup
Catalytic triad wikipedia , lookup
Biochemical cascade wikipedia , lookup
Metabolic network modelling wikipedia , lookup
Two-hybrid screening wikipedia , lookup
Promoter (genetics) wikipedia , lookup
Transcriptional regulation wikipedia , lookup
Mitogen-activated protein kinase wikipedia , lookup
Gene regulatory network wikipedia , lookup
Expression vector wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Silencer (genetics) wikipedia , lookup
JBA-06343; No of Pages 13 Biotechnology Advances xxx (2010) xxx–xxx Contents lists available at ScienceDirect Biotechnology Advances j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / l o c a t e / b i o t e c h a d v Research review paper Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of L-threonine Xunyan Dong a, Peter J. Quinn b, Xiaoyuan Wang a,⁎ a b State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China Department of Biochemistry, King's College London, 150 Stamford Street, London SE1 9NH, United Kingdom a r t i c l e i n f o Article history: Received 14 May 2010 Received in revised form 17 July 2010 Accepted 26 July 2010 Available online xxxx Keywords: Escherichia coli Corynebacterium glutamicum L-threonine production Metabolic engineering L-threonine biosynthesis a b s t r a c t L-threonine is an essential amino acid for mammals and as such has a wide and expanding application in industry with a fast growing market demand. The major method of production of L-threonine is microbial fermentation. To optimize L-threonine production the fundamental solution is to develop robust microbial strains with high productivity and stability. Metabolic engineering provides an effective alternative to the random mutation for strain development. In this review, the updated information on genetics and molecular mechanisms for regulation of L-threonine pathways in Escherichia coli and Corynebacterium glutamicum are summarized, including L-threonine biosynthesis, intracellular consumption and trans-membrane export. Upon such knowledge, genetically defined L-threonine producing strains have been successfully constructed, some of which have already achieved the productivity of industrial producing strains. Furthermore, strategies for strain construction are proposed and potential problems are identified and discussed. Finally, the outlook for future strategies to construct industrially advantageous strains with respect to recent advances in biology has been considered. © 2010 Elsevier Inc. All rights reserved. Contents 1. 2. 3. 4. 5. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . The metabolic pathway of L-threonine. . . . . . . . . . . . . . . . . . . . 2.1. Production of L-threonine . . . . . . . . . . . . . . . . . . . . . . 2.2. Intracellular consumption of L-threonine . . . . . . . . . . . . . . . 2.3. Export of L-threonine . . . . . . . . . . . . . . . . . . . . . . . . Regulation mechanism of L-threonine biosynthesis pathway . . . . . . . . . 3.1. Mechanisms of repression . . . . . . . . . . . . . . . . . . . . . . 3.2. Mechanisms of inhibition . . . . . . . . . . . . . . . . . . . . . . Progress in strain construction . . . . . . . . . . . . . . . . . . . . . . . 4.1. L-threonine producing strains of E. coli . . . . . . . . . . . . . . . . 4.1.1. Overexpressing the thr operon. . . . . . . . . . . . . . . . 4.1.2. Enhancing L-threonine export . . . . . . . . . . . . . . . . 4.1.3. Systems metabolic engineering . . . . . . . . . . . . . . . 4.2. L-threonine producing strains of C. glutamicum . . . . . . . . . . . . 4.2.1. Overexpressing genes in the L-threonine biosynthesis pathway 4.2.2. Reducing the L-threonine consumption . . . . . . . . . . . 4.2.3. Enhancing the L-threonine export . . . . . . . . . . . . . . Outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5.1. Engineering the pathway . . . . . . . . . . . . . . . . . . . . . . 5.2. Enzymes engineering . . . . . . . . . . . . . . . . . . . . . . . . 5.3. Improving production stability . . . . . . . . . . . . . . . . . . . . 5.4. Extending the substrate spectrum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ⁎ Corresponding author. State Key Laboratory of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi 214122, China. Tel./fax: +86 510 85329239. E-mail address: [email protected] (X. Wang). 0734-9750/$ – see front matter © 2010 Elsevier Inc. All rights reserved. doi:10.1016/j.biotechadv.2010.07.009 Please cite this article as: Dong X, et al, Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of Lthreonine, Biotechnol Adv (2010), doi:10.1016/j.biotechadv.2010.07.009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 X. Dong et al. / Biotechnology Advances xxx (2010) xxx–xxx 6. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1. Introduction L-threonine has been widely used as a supplement in the food, pharmaceutical and cosmetics industries. Its demand has been growing steadily. The most remarkable use of L-threonine is as a feed additive, as recent studies have acknowledged L-threonine as the second limiting amino acid in swine feeds after L-lysine and the third limiting amino acid in poultry feeds after L-lysine and L-methionine (Ajinomoto, 2009). Application of low protein level formula feeds supplemented with L-threonine is not only economically advantageous, but also contributes to the relief of crude protein deficiency and lower nitrogen emissions. Thus, the production of L-threonine is being rapidly developed (Leuchtenberger et al., 2005). The global production capacity of L-threonine was about 75,000 tons in 2009 (Ajinomoto, 2009), while the annual demand in the Chinese feed additive industry alone will exceed 60,000 tons in 2010. Currently L-threonine is produced mainly by microbial fermentation. Ever since Kinoshita et al. (1958) first reported glutamate production by Corynebacterium glutamicum, great interest has been inspired in research into microbial production of L-threonine, resulting in the industrial prosperity of today. Through breeding approaches, researchers have developed L-threonine producing strains of Serratia marcescens (Komatsubara et al., 1978), Escherichia coli (Furukawa et al., 1988) and C. glutamicum (Morinage et al., 1987). To date, E. coli mutant strains remain the dominant industrial producers of L-threonine, followed by C. glutamicum. The current and future demand for L-threonine provides a strong impetus to further improve productivity of the bioconversion and reduce its costs. The most efficient solution is to develop more productive bacterial strains with reduced growth retardation. Strains surviving multiple rounds of mutation are genetically undefined and vulnerable to further changes, occurring especially from random mutations, which at best will result in marginal increases in yield and resistance to more stringent process requirements. Obviously, directed genetic manipulations are more feasible options for subsequent isolation of mutant strains of genetically defined hyper-producers. Selection criteria would include reduced by-product formation and expanded substrate spectra. By all accounts, it is by genetic engineering that breakthroughs in efficient and clean L-threonine production will be achieved. This review covers development of L-threonine producers of E. coli and C. glutamicum through genetic manipulation over the past two decades. We focus on the pathways of anabolism and catabolism of L-threonine as well as its export from the cell. The mechanisms of regulation of L-threonine production at the molecular level are considered. Also, progress in strain construction based on metabolic engineering and systems biology is discussed. The currently employed strategies are summarized and problems are identified. Future prospects are illustrated with respect to contemporary knowledge of biology and by examples in development of hyper-producers of other amino acids. 2. The metabolic pathway of L-threonine L-threonine, which belongs to the aspartic family of amino acids, is synthesized from L-aspartate (Fig. 1). Five enzymes, aspartate kinase, aspartyl semialdehyde dehydrogenase, homoserine dehydrogenase, homoserine kinase and threonine synthase are involved in the biosynthesis of L-threonine (Table 1). Both E. coli and C. glutamicum 0 0 0 share common L-lysine and L-methionine competing branches, but C. glutamicum also possesses additional biosynthesis pathways for both L-lysine (Schrumpf et al., 1991) and L-methionine (Rückert et al., 2003). L-threonine can be consumed to synthesize L-isoleucine and glycine in the cell, or be exported out of the cell. 2.1. Production of L-threonine Aspartate kinase, the first key enzyme in the L-threonine biosynthesis pathway, phosphorylates aspartate to form aspartyl-P, thus, serving to direct the carbon flux into the aspartate family of amino acids. In E. coli, three aspartate kinase isoenzymes are known, designated aspartate kinase I, II and III, differing in their genetic determination and regulation mechanisms (Chassagnole et al., 2001; Viola, 2001). Aspartate kinase I, the most abundant of the three enzymes, is encoded by the thrA gene. The expression of thrA is repressed by L-threonine and L-isoleucine in a covalent manner and the activity of aspartate kinase I is feed-back inhibited by L-threonine. Aspartate kinase II, the least abundant isoform, is encoded by the metL gene. The expression of metL is repressed by L-methionine but the activity of aspartate kinase II is not inhibited by any amino acid from the aspartate family. Aspartate kinase III is the product of the lysC gene. The expression of lysC is repressed by L-lysine and the activity of aspartate kinase III is inhibited also by L-lysine. Aspartate kinase I and II are bifunctional enzymes with two catalytic domains, one for aspartate kinase activity and the other for homoserine dehydrogenase activity (Katinka et al., 1980). Therefore, they are also named as aspartate kinase I–homoserine dehydrogenase I and aspartate kinase II–homoserine dehydrogenase II. In C. glutamicum, aspartate kinase is encoded only by the lysC gene. Its activity is synergistically inhibited by L-threonine and L-lysine (Shiio and Miyajima, 1969). Although the enzymes involved in the biosynthesis pathway of L-threonine are believed to have no isoenzyme components, deletion of lysC was detrimental but not lethal to a C. glutamicum strain grown on minimal media (Jetten et al., 1995). In both E. coli and C. glutamicum, aspartyl semialdehyde dehydrogenase is encoded by the asd gene. It catalyses deoxidization of aspartyl-P to form aspartyl semialdhyde (Fig. 1). Expression of asd in E. coli is subjected to multivalent repression by L-lysine, L-threonine and L-methionine (Boy and Patte, 1972) but there is no evidence of feed-back inhibition of its protein product. In C. glutamicum, the expression of asd is not influenced by any of the aspartic amino acids, nor is the activity of its product (Cremer et al., 1988). Homoserine dehydrogenase is the second key enzyme of the pathway, controlling carbon flux toward L-homoserine synthesis (Fig. 1). It competes for a common substrate, aspartyl semialdehyde, with dihydrodipicolinate synthase, which catalyses the first step of the L-lysine biosynthesis branch. In E. coli, as mentioned above, two isoenzymes of homoserine dehydrogenase are known, both of which are present as catalytic domains in the bifunctional aspartate kinase I–homoserine dehydrogenase I and aspartate kinase II–homoserine dehydrogenase II. Homoserine dehydrogenase I is subjected to inhibition by L-threonine (Chassagnole et al., 2001). The level of homoserine dehydrogenase II has been seldom analyzed because aspartate kinase II–homoserine dehydrogenase II is present only in small amounts in vivo. In C. glutamicum, homoserine dehydrogenase is encoded by hom (Follettie et al., 1988). Expression of hom is slightly feed-back repressed by L-methionine (Miyajima and Shiio, 1971) Please cite this article as: Dong X, et al, Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of Lthreonine, Biotechnol Adv (2010), doi:10.1016/j.biotechadv.2010.07.009 X. Dong et al. / Biotechnology Advances xxx (2010) xxx–xxx 3 Fig. 1. The biosynthesis pathway of L-threonine. The pathway consists of five enzymatic steps. The first, third, and fourth reactions are catalyzed by the three key enzymes aspartate kinase, homoserine dehydrogenase, and homoserine kinase, respectively. These enzymes are subjected to feed-back inhibition by L-threonine. There are four competing pathways that affect the biosynthesis and accumulation of L-threonine, leading to formation of L-lysine, L-methionine, L-isoleucine, and glycine. and activity of homoserine dehydrogenase is feed-back inhibited by L-threonine (Miyajima and Shiio, 1970). The conversion of L-homoserine to L-threonine is carried out by homoserine kinase and threonine synthase. Homoserine kinase phosphorylates homoserine to form homoserine-P which is then dephosphorylated by threonine synthase to form L-threonine (Fig. 1). Homoserine kinase is the third key enzyme of the pathway; it controls carbon flux toward L-threonine synthesis. It competes for the common substrate, homoserine, with acetyltransferase, the first enzyme of the L-methionine branch. In both E. coli and C. glutamicum, homoserine kinase is encoded by the thrB gene and threonine synthase by the thrC gene. In E. coli, thrB and thrC are clustered with thrA in the thr operon, and their expression is subjected to covalent repression by L-threonine and L-isoleucine (Theze and Saint-Girons, 1974). The activity of homoserine kinase is inhibited by L-threonine and L-isoleucine, whereas the activity of threonine synthase is not subjected to feed-back inhibition (Chassagnole et al., 2001). In C. glutamicum, expression of thrB is slightly feed-back repressed by L-methionine and the activity of Please cite this article as: Dong X, et al, Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of Lthreonine, Biotechnol Adv (2010), doi:10.1016/j.biotechadv.2010.07.009 4 X. Dong et al. / Biotechnology Advances xxx (2010) xxx–xxx Table 1 Enzymes and their coding genes related to the production of L-threonine. Enzymes Genes Function Aspartate kinase thrA; metL; lysC Aspartyl semialdehyde dehydrogenase Homoserine dehydrogenase asd thrA; metL; hom Homoserine kinase Threonine synthase Threonine dehydratase thrB thrC tdcB; ilvA Threonine dehydrogenase Threonine aldolase Serine hydroxymethyl transferase Permease tdh ltaE glyA rhtA; rhtB; rhtC; thrE Phosphorylate aspartate to form aspartyl-P. There are three coding genes (thrA, metL, lysC) in E. coli, but only one (lysC) in C. glutamicum. Deoxidize aspartyl-P to form aspartyl semialdehyde. Remove the carboxyl group of aspartyl semialdehyde. There are two coding genes (thrA; metL) in E. coli, but only one (hom) in C. glutamicum. Add a phosphate group to homoserine to form homoserine-P. Remove the phosphate group of homoserine-P to form threonine. Consume threonine to produce isoleucine. There are two coding genes (tdcB; ilvA) in E. coli, but only one (ilvA) in C. glutamicum. Consume threonine to produce glycine in E. coli. Consume threonine to produce glycine in E. coli. Consume threonine to produce glycine in C. glutamicum. Transport threonine from inside to the outside of cell. There are three coding genes (rhtA; rhtB and rhtC) in E. coli, but only one (thrE) in C. glutamicum. homoserine kinase is feed-back inhibited by L-threonine, whereas threonine synthase is not subjected to feed-back regulation by any amino acid from the aspartic family (Follettie et al., 1988). 2.2. Intracellular consumption of L-threonine L-threonine is the precursor for the synthesis of L-isoleucine and glycine. The first enzyme in the biosynthesis pathway of L-isoleucine from L-threonine is threonine dehydratase. In C. glutamicum threonine dehydratase is encoded by the ilvA gene (Mockel et al., 1992). In addition to ilvA (Umbarger and Brown, 1957), E. coli has another gene, tdcB, encoding threonine dehydratase, which is expressed under anaerobic conditions (Umbarger, 1973). The glycine biosynthesis pathways differ between E. coli and C. glutamicum. In C. glutamicum, a side activity of serine hydroxymethyl transferase encoded by the glyA gene fulfills the function of cleaving L-threonine directly into glycine and acetaldehyde (Simic et al., 2002). The main substrate of this enzyme is L-serine with which the cleavage activity is 24-fold higher than with L-threonine. In E. coli, two enzymes, threonine dehydrogenase encoded by the tdh gene (Bell and Turner, 1976) and threonine aldolase encoded by the ltaE gene (Liu et al., 1998), have been found to be responsible for conversion of L-threonine to acetaldehyde and glycine. However, only when the cellular glycine is lacking will the threonine aldolase function as a compensatory force. 2.3. Export of L-threonine Several studies have demonstrated that secretion could be the limiting factor in amino acid production (Morbach et al., 1996; Reinscheid et al., 1994). In C. glutamicum, export of L-threonine could be proceeded by both passive diffusion and carrier-mediated excretion, the latter accounting for more than 90% of the total efflux (Palmieri et al., 1996). To date, five permeases have been found in E. coli (Eggeling and Sahm, 2003). They confer resistance to high concentration of L-threonine to the producing strains. However, only three of the permeases show activity in exporting L-threonine out of cell. They are RhtA, RhtB and RhtC encoded by genes rhtA, rhtB and rhtC, respectively (Livshits et al., 2003; Kruse et al., 2002). The former is believed to be a member of the drug/metabolite transporter super family, while the latter two belong to the RhtB translocator super family (Eggeling and Sahm, 2003). RhtA catalyses efflux of both L-threonine and L-homoserine, while RhtB and RhtC are specific exporters for L -threonine (Diesveld et al., 2009). RhtC has a higher activity than RhtB. So far, ThrE is the only identified protein showing activity for exporting L-threonine in C. glutamicum (Simic et al., 2001). It is encoded by the thrE gene, and can export both L-threonine and L-serine. ThrE has a low affinity with L-threonine, suggesting its main function might not be as an exporter for L-threonine. 3. Regulation mechanism of L-threonine biosynthesis pathway Advances in molecular biology have made the study of metabolic regulation of amino acid biosynthesis possible at the molecular level. So far, the mechanisms of feed-back repression of the expression of thrA and lysC in E. coli, and hom and thrB in C. glutamicum have been provisionally explained at the genetic level (Grundy et al., 2003; Mateos et al., 1994; Theze and Saint-Girons, 1974); the mechanisms of feedback inhibition of aspartate kinase III in E. coli and aspartate kinase in C. glutamicum have been elucidated upon their three-dimensional protein structures (Kotaka et al., 2006; Yoshida et al., 2007). Such information serves as a theoretical basis of rational enzyme modification. Thus allosteric modulation of enzymes could be done using a genetic approach so that they lose sensitivity to inhibitors while their activity is unaffected or even enhanced by precise position modification. Nevertheless, some loss of enzymatic activity was frequently observed as was also the case in modifying substrate specificity. The determination of the three-dimensional enzyme structure from which precise binding sites for small molecule effectors can be identified may also be helpful in providing positive outcomes. 3.1. Mechanisms of repression The covalent repression of expression of E. coli thrA by L-threonine and L-isoleucine can be ascribed to the transcriptional attenuation of the thr operon, which consists of three structural genes thrA, thrB and thrC (Theze and Saint-Girons, 1974). A leader sequence thrL containing 178 base pairs precedes the first structural gene thrA. An internal region of the leader sequence potentially encodes a short peptide with eight threonine codons and four isoleucine codons, eleven of which are arranged in tandem. The downstream region of the tandem codons could participate in the formation of a stem and loop structure by base pairing (Fig. 2). When the intracellular L-threonine and L-isoleucine are in excess, ribosome can read through the leader sequence and the stem and loop structure of a terminator forms, so the transcription of thr operon is pre-terminated (Fig. 2A). By contrast, when L-threonine and L-isoleucine are lacking, translation of the short peptide stalls, and an alternative stem and loop structure forms, preventing the formation of a terminator, so the transcription of thr operon can proceed (Fig. 2B). Mutation of a G insertion at position −37 was believed to change the stability of the terminator, and was confirmed to cause derepression (Gardner and Reznikoff, 1978; Gardner, 1979). Expression of E. coli lysC is also repressed by L-lysine through translational attenuation. When L-lysine is in excess, the leader region preceding the structural gene lysC can form six helixes via internal base pairing during transcription (Fig. 3A). Helix 6 contains the ShineDalgarno (SD) sequence and prevents the binding of the ribosome to mRNA, so that the translation of lysC cannot be initiated (Fig. 3A). On Please cite this article as: Dong X, et al, Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of Lthreonine, Biotechnol Adv (2010), doi:10.1016/j.biotechadv.2010.07.009 X. Dong et al. / Biotechnology Advances xxx (2010) xxx–xxx 5 Fig. 2. Transcriptional attenuations of the thr operon in E. coli. Secondary structures of the leader sequence of mRNA of the thr operon are proposed. The leader sequence encodes a short peptide containing tandem threonine and isoleucine codons. A. When the intracellular L-threonine and L-isoleucine are in excess, ribosome can read through the leader sequence and the stem and loop structure of a terminator forms, so the transcription of thr operon is pre-terminated. B. When L-threonine and L-isoleucine are lacking, translation of the short peptide stalls, and an alternative stem and loop structure forms, preventing the formation of a terminator, so the transcription of thr operon can proceed. The tandem threonine and isoleucine codons and the stop codon in the leader sequence are underlined. The regions which alternatively participate in the formation of the terminator or the antiterminator are also underlined. These models were built by using the RNAfold web server (Gruber et al., 2008; Hofacker et al., 1994) and the published information (Gardner 1979). the other hand, when L-lysine is deficient, the helix 1 and the helix 6 are released and a new helix 7 is formed. The SD sequence now is available, and therefore the translation of lysC can proceed (Fig. 3B) (Grundy et al., 2003). In C. glutamicum, hom and thrB are clustered in the same operon in the direction of 5′-hom-thrB-3′ on the chromosome with an internal non-coding space of 10 bp. The feed-back repression of the expression of hom and thrB by L-methionine might be ascribed to a transcriptional attenuation-like regulation of the hom-thrB operon, because there is a long reversibly repeated sequence upstream of hom, which was apt to form a stem structure with a △G of -16.2 kJ/mol (Mateos et al., 1994). Expression of the genes subjected to such regulation may need additional regulatory proteins (Henkin and Yanofsky, 2002; Mateos et al., 1994). Detailed analysis revealed existence of two promoters in the hom-thrB operon. The one upstream of hom was believed to initiate co-transcription of hom and thrB in C. glutamicum. The other promoter inside the coding region of hom might be functional for individual transcription of thrB. Transcription from both promoters is arrested by the same terminator downstream of thrB. From this it was inferred that the transcription of thrB might be more efficient than that of hom (Mateos et al., 1994). Subsequent results reported by Diesveld et al. (2009), however, reached the opposite conclusion. Thus, the transcription mode of hom-thrB operon remains unclear, and the evidence of transcriptional attenuation needs further investigation. 3.2. Mechanisms of inhibition E. coli aspartate kinase I–homoserine dehydrogenase I is a homotetramer and each peptide chain contains two catalytic domains, with the kinase site residing on the N-terminal region and the dehydrogenase Fig. 3. Translational attenuation of the lysc gene in E. coli. Secondary structures of the leader sequence of mRNA of the lysc gene are proposed. A. When L-lysine is in excess, the leader region preceding the structural gene lysC can form six helixes during transcription. Helix 6 contains the SD sequence and prevents the binding of the ribosome to mRNA, so the translation of lysC can not be initiated. B. When L-lysine is deficient, helix 1 and helix 6 are released and a new helix 7 is formed. The SD sequence now is available, and therefore the translation of lysC can proceed. The SD sequence and the sequence which alternatively participates in the formation of helix 1 or helix 7 are underlined. These structural models were built by using the RNAfold web server (Gruber et al., 2008; Hofacker et al., 1994) and the published information (Grundy et al. 2003). Please cite this article as: Dong X, et al, Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of Lthreonine, Biotechnol Adv (2010), doi:10.1016/j.biotechadv.2010.07.009 6 X. Dong et al. / Biotechnology Advances xxx (2010) xxx–xxx site residing on the C-terminal region. Between the two catalytic domains an interphase region is located, which is responsible for allosteric regulation by L-threonine (Fazel et al., 1983). Aspartate kinase I is partially inhibited by L-threonine, and the inhibitory mechanism is allosteric and competitive with L-aspartate. Homoserine dehydrogenase I is also partially inhibited by L-threonine, but the inhibitory mechanism is non-competitive (Chassagnole et al., 2001). Previously it was reported that the inhibition of homoserine dehydrogenase I was mediated through the aspartate kinase I domain (Truffa-Bachi et al., 1974), but subsequently James and Viola (2002a) constructed chimeric enzymes and found that monofunctional aspartate kinase I was released from L-threonine inhibition and monofunctional homoserine dehydrogenase I also lost sensitivity to L-threonine inhibition. Homoserine dehydrogenase I with an interphase region, however, became even more sensitive to L-threonine inhibition. Furthermore, confusion of aspartate kinase III and homoserine dehydrogenase I containing an interphase region conferred on homoserine dehydrogenase I an additional sensitivity to L-lysine with its L-threonine sensitivity retained (James and Viola, 2002a). Thus the mechanism of inhibition remains ambiguous until a high-resolution structure of aspartate kinase I–homoserine dehydrogenase I is available. The inhibition of E. coli aspartate kinase III by L-lysine is complete, and the inhibitory mechanism is non-competitive and co-operative (Chassagnole et al., 2001). The functional E. coli aspartate kinase III is a homodimer (Fig. 4A). The N-terminal region of each subunit functions as a catalytic domain, containing binding sites for L-aspartate (Thr-45, Glu-119, Arg-198, Ser-201) and ATP (Lys-8, Gly-11, Ser-39, Thr-221, Asp-222, Tyr-227, Arg-232, Lys-257). Inadequate contact of L-aspartate with E. coli aspartate kinase III is responsible for its overlapping substrate specifity. The C-terminal region serves as a regulatory domain, containing two ACT domains, ACT1 (residues 308-384) and ACT2 (residues 386-439) which are arranged perpendicularly. The ACT (Acronym for aspartate kinase, Chorismate mutase and TyrA) domain is structurally conserved and involved in binding small-molecule regulatory ligands found in functionally diverse proteins (Chipman and Shaanan, 2001). The interface of the two ACT1 domains from different subunits shapes binding sites for two L-lysine molecules (Met-318, Ser-321, Phe-324, Leu-325, Ser-338, Val-339, Asp-340, Ser345, Glu-346) (Fig. 4). Mutations of T344M, S345L, T352I have been confirmed to be associated with partial L-lysine resistance. ACT2 which does not bind any effector molecule stabilizes the dimer and transmits an L-lysine binding signal to the catalytic domain. The mechanism of inhibition involves tetramerization of two dimers resulting from L-lysine binding via hydrogen bond of N-terminal (Leu-104, Ser-107) and concomitant allosteric transition of both regulatory and catalytic domains. These results in blockage of the ATP binding site and eventually activity lost. Furthermore, the allosteric transition disrupts one hydrogen bond at the L-aspartate binding site, which does not affect the substrate binding ability but may reduce conversion rate (Kotaka et al., 2006). In E. coli, the entire amino acid sequence of aspartate kinase III is homologous to the N-terminal region of aspartate kinase I–homoserine dehydrogenase I and aspartate kinase II–homoserine dehydrogenase II, and the identity between aspartate kinase III and aspartate kinase I–homoserine dehydrogenase I is higher than that between aspartate kinase III and aspartate kinase II–homoserine dehydrogenase II (Cassan et al., 1986). Bioinformatic analysis revealed that aspartate kinase III might be the prototype of aspartate kinase I and aspartate kinase II (Fondi et al., 2007). The duplication of lysC and the following fusion between the redundant copy of lysC and the gene encoding homoserine dehydrogenase might give rise to a bifunctional aspartate kinase– homoserine dehydrogenase; then the duplication and divergence of the prototype gene encoding the aspartate kinase–homoserine dehydrogenase might give rise to thrA and metL. Conserved residues of aspartate kinase I, II and III have been identified. They are Lys-8 and Asp-202 for phosphoryl transferation, Thr-45, Glu-119 and Arg-198 for L-aspartate binding, Asp-222 and Arg-232 for ATP binding (Kotaka et al., 2006). The inhibition of E. coli homoserine kinase is complicated. It is inhibited by substrate, L-homoserine, in the concentration of more than 1 mM and ATP of more than 3 mM in a hypothetic “preferred order” manner, by L-threonine in a competitive manner, and by L-lysine in a non-competitive manner (Chassagnole et al., 2001). So far, no molecular mechanism has been proposed. In C. glutamicum, aspartate kinase is a heterotetramer, comprised of two α subunits and two β subunits. The two types of subunits are encoded by a single gene lysC, containing an in-frame sequence overlap (Kalinowski et al., 1990). The N-terminal region of the α subunit functions as the catalytic domain, while the C-terminal region together with the β subunit serves as a regulatory domain (Kato et al., 2004). Each β subunit contains two ACT domains, ACT1 and ACT2, which are arranged perpendicularly to each other (Fig. 5A). Association of an ACT1 from one β subunit and an ACT2 from the other forms an L-threonine binding site (Ile-23, Asp-25, Pro-27, Gly-28, Ala-30, Ala-31, Gln-49, Fig. 4. The detailed structure of L-lysine binding site in the E. coli aspartate kinase III. A. The dimer structure of the regulatory domains is shown. ACT1 and ACT2 domains of chain A are shown in green and yellow, respectively. ACT1 and ACT2 domains of chain B are shown in blue and purple, respectively. Atoms of the regulatory effector L-lysine are shown in red. B. The amino acid residues involved in binding L-lysine are shown in the manner of sticks. Residues from chain A and chain B are shown in green and cyan, respectively. The bound L-lysine molecule is shown in orange. These models are built by using the PyMOL software, Protein Data Bank (accession number 2J0X) and the published information by Kotaka et al. (2006). Please cite this article as: Dong X, et al, Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of Lthreonine, Biotechnol Adv (2010), doi:10.1016/j.biotechadv.2010.07.009 X. Dong et al. / Biotechnology Advances xxx (2010) xxx–xxx 7 Fig. 5. The structure of L-threonine binding site in the β subunit of C. glutamicum aspartate kinase. A. The dimer structure of the β subunits is shown. ACT1 and ACT2 domains of chain A are shown in yellow and green, respectively. ACT1 and ACT2 domains of chain B are shown in blue and purple, respectively. Atoms of the regulatory effector L-threonine are shown in red. B. The amino acid residues directly involved in binding L-threonine are shown in the manner of sticks. Residues from chain A are shown in green and residues from chain B in cyan. The bound L-threonine molecule is shown in orange. These structural models are built by using the PyMOL software, Protein Data Bank (accession number 2DTJ) and the published information by Yoshida et al. (2007). Thr-59, Ile-61, Val-124, Ile-126), causing dimerization of two β subunits (Fig. 5B). Thus the dimer of β subunits has two L-threonine binding sites and the binding of L-threonine stabilizes the dimer structure. The L-lysine binding site has not been precisely characterised so far, but is constrained to an area of around the residue 50 or the residues 105 to 115. Since the β subunit is identical to about 160 residues of C-terminus of the α subunit, it was postulated that dimerization between the two rather than homodimerization between two β subunits is the practical situation responsible for inhibitory regulation. As for L-lysine, both α subunits and β subunits may contain recognition sites for this amino acid. The mechanism of inhibition may involve firstly the binding of L-threonine to produce a stable dimerization of regulatory domains followed by L-lysine binding leading to a conformational change in the catalytic domains, causing loss of catalytic activity of aspartate kinase. Yoshida et al. (2007) analyzed the L-lysine analog S-(2aminoethyl)-l-cysteine resistant C. glutamicum strains and found that mutations were contained in the regulatory domains of aspartate kinase. In C. glutamicum, homoserine dehydrogenase is subjected to feedback inhibition by L-threonine. The wild type homoserine dehydrogenase can be completely inhibited by 2 mM L-threonine. Mutation of homoserine dehydrogenase by replacing residue Gly378 with Glu conferred L-threonine resistance (Reinscheid et al., 1991). It was not inhibited by L-threonine even in concentrations of 25 mM, and the concentration for half maximal inhibition was 100 mM. Furthermore, the residue 378 was confirmed to be essential since both the size and charge of the amino acid at that position affected the inhibitory regulation of homoserine dehydrogenase. In addition, threonine binding site is located in the C-terminal region of the enzyme (Archer et al., 1991). C. glutamicum homoserine kinase is also subjected to weak feed-back inhibition by L-threonine with the concentration for a half maximal inhibition of 25 mM for wild type (Colon et al., 1995). Studies on the kinetics of enzymatic activity showed that the inhibition by L-threonine was competitive and could be relieved as the concentration of L-homoserine substrate increased (Miyajima et al., 1968). Due to the competitive mechanism of inhibition that substrate and inhibitor compete for the same binding site, it is really a challenging task to construct a desensitized homoserine kinase by changing its conformation through site mutagenesis, and yet not affect the catalytic characteristics. The only reported strategy was to increase homoserine accumulation by overexpression of hom (Colon et al., 1995). Judging from this fact and from their genetic relationship, homoserine dehydrogenase and homoserine kinase were postulated to be functionally correlated (Follettie et al., 1988; Peoples et al., 1988). 4. Progress in strain construction The strategies for construction of L-threonine producers can be summarized as follows: (1) overexpressing the genes encoding the key enzymes of the biosynthesis pathway to condense carbon influx, (2) weakening the competing branches to save more available precursors and reduce formation of unwanted products, (3) reducing intracellular consumption, (4) enhancing L-threonine secretion, (5) integrating (1) to (4) by systematic approaches. Overexpressing the genes encoding the key enzymes of the biosynthesis pathway, especially the deregulated ones, is usually the most productive strategy. Nevertheless, the outcomes of this strategy do not always meet with expectations. The efficiency of the approach depends partly on the localization of the product and its role in cellular metabolism. For example, application of this strategy only resulted in a slight increase in L-serine accumulation (Wendisch et al., 2005), but led to significant enhancements in L-lysine synthesis (Cremer et al., 1991) and L-threonine production (Eikmanns et al., 1991; Reinscheid et al., 1994). A computational analysis of the global metabolic net of E. coli indicated that the L-threonine biosynthesis pathway along with its conversion into glycine was a part of the highflux backbone of metabolism, which meant that L-threonine played a crucial role in cellular metabolism (Almaas et al., 2004). Hartman (2007) reported that the synthesis and uptake of L-threonine was of great significance for Saccharomyces cerevisiae to maintain cell stability, as L-threonine could be converted into glycine and subsequently to initiate de-novo purine synthesis. Curien et al. (2009) found that in Arabidopsis L-threonine played an integrative regulatory role in L-aspartate metabolic distribution. All such information theoretically supports the fact that overexpression of the genes involved in biosynthesis efficiently leads to increased L -threonine production, but due to its physiological importance, accumulation of intracellular L-threonine is severely restricted. In practice, the increase of the genes expression and consequent L-threonine production are mutually inconsistent (Colon et al., 1995; Eikmanns et al., 1991). When L-threonine accumulates to a certain level, the prompt secretion becomes limiting for production. Even for Gram-negative E. coli, whose cell envelope is not considered as a permeation barrier for amino acids, it was reported that the intracellular concentration of L-threonine exceeded the one observed in medium throughout the fermentation process, with a 10-fold excess observed in early stages of the process (Kruse et al., 2002). Gram-positive C. glutamicum possesses a characteristic cell wall structure, containing an outer layer Please cite this article as: Dong X, et al, Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of Lthreonine, Biotechnol Adv (2010), doi:10.1016/j.biotechadv.2010.07.009 8 X. Dong et al. / Biotechnology Advances xxx (2010) xxx–xxx of mycolic acids (Eggeling and Sahm, 2001), the amino acid efflux in C. glutamicum is therefore significantly impaired. High intracellular concentrations of L-threonine down-regulate the biosynthesis enzymes in a feed-back manner, increase the precursor availability for the consuming pathway, and even inhibit cell growth. Overexpressing the specific permease-coding genes not only accelerates L-threonine export, conferring strains with L-threonine-resistant phenotype, but also contributes to reduced consumption, since L-threonine permease and L-threonine consuming enzymes compete for the same substrate (Simic et al., 2002). Reducing intracellular L-threonine conversion towards L-isoleucine in E. coli with genotype of relA+ results in activation of the thr operon via a “stringent response” mechanism in addition to a derepression effect (Debabov, 2003). A comprehensive strategy with integration of systems biology, also referred to as systems metabolic engineering, gives rise to breakthroughs in strain construction. So far, a few E. coli L-threonine hyperproducers have been constructed by this means, and the total conversion rate of glucose to L-threonine and biomass approximates to the predicted theoretical values. 4.1. L-threonine producing strains of E. coli 4.1.1. Overexpressing the thr operon As thrA, thrB, and thrC are clustered in the thr operon, and aspartate kinase I encoded by thrA exists most abundantly among the three aspartate kinases, engineering of the L-threonine branch has been focused on this operon (Table 2). In 1983, Miwa et al. introduced a recombinant plasmid pBR322-thrAr into a desensitized E. coli mutant strain βIM4, as a result, L-threonine production was increased by three-fold reaching 13.4 g/L (Miwa et al., 1983). In 2003, Livshits et al. (2003) introduced a recombinant plasmid pVIC40 containing the mutant operon thrA442BC into the desensitized E. coli strain MG442, as a result, L-threonine production was increased from 8 g/L to 18.4 g/L. In 2009, Zhang et al. introduced a high-copy number recombinant plasmid pWYE134 containing a mutated operon thrA345BC under its native promoter into the wild type strain E. coli W3110. Because the thrL gene encoding the leader peptide was included, the expression of the operon was subjected to feed-back repression by L-threonine and L-isoleucine, but the activity of aspartate kinase I was relieved from L-threonine inhibition. As a result, L-threonine production was increased from 0.036 g/L to 9.2 g/L in fed-batch fermentation (Zhang et al., 2009a). 4.1.2. Enhancing L-threonine export Kruse et al. (2002) constructed E. coli MG422 (pTrc99A-rhtB), MG422 (pTrc99A-rhtC) and MG422 (pTrc99A-thrECg) in which either a homologous or a heterologous gene involved in export of L-threonine was overexpressed. As a result, L-threonine production was increased by 140%, 200% and 290%, respectively, when compared with the control strain MG422 (pTrc99A). Livshits et al. (2003) constructed E. coli MG422 rhtA23 (pAYC32-thrArBC), in which rhtA expression was enhanced by a point mutation (G → A) one base upstream the start codon of rhtA in the chromosome, L-threonine production was increased from 18.4 g/L to 36.3 g/L. 4.1.3. Systems metabolic engineering In 2007, Lee et al. constructed an L-threonine hyper-producer, TH28C (pBRThrABCR3), from a lacI- mutant strain of E. coli W3110 in which promoters such as Ptac and Ptrc could initiate transcription constitutively. Several strategies have been used in this construction. First, the feed-back inhibitions of aspartate kinase I and III were released through site-directed mutagenesis of their coding genes, thrA and lysC in chromosome; the feed-back repression to the chromosomal thr operon was released by the promoter substitution with Ptac, and the deregulated thr operon was overexpressed on an episomal vector. Secondly, the biosynthesis of L-lysine was blocked by deleting Table 2 Genetically engineered L-threonine producers. Strains Yield (g/L) Reference Overexpressing genes in L-threonine synthesis pathway E. coli 13.4 βIM4(pBR322-thrAr) 18.4 MG422(pAYC32-thrArBC) r 9.2 W3110(pMD19-thrLA BC) C. glutamicum r DM368-3(pEK-hom -thrB) 1.7 7.7 MH20-22B-(homr-thrB)3 8.2 MH20-22B (pWK-homr-thrB) ATCC21799(pGC42) 11.8 DM1800(pET-T18homr-thrB-thrE) 2.5a Reducing L-threonine consumption C. glutamicum DM368-2glyA’ DM1800ilvAM (pET-T18homr-thrB-thrE) Enhancing L-threonine export E. coli MG422(pTrc99A-rhtB) MG422(pTrc99A-rhtC) MG422(pTrc99A-thrECg) MG422 rhtA23(pAYC32-thrArBC) C. glutamicum MH20-22B-(homr-thrB)3 (pEC-T18mob2-thrE) DM368-2glyA’(pEC-T18mob2-thrE) DM368-3(pEKEx2-rhtCEc) DM1800(pET-T18homr-thrB-thrE) (pEKEx2-rhtCEc) Systems metabolic engineering E. coli TH28C (pBRThrABCR3) MDS-205 a Miwa et al., 1983 Livshits et al., 2003 Zhang et al., 2009a Eikmanns et al., 1991 Reinscheid et al., 1994 Reinscheid et al., 1994 Colon et al., 1995 Diesveld et al., 2009 1.3a 4a Simic et al., 2002 Diesveld et al., 2009 (140% Increase) (200% Increase) (290% Increase) 36.3 (100% Increase) Kruse et al., 2002 Kruse et al., 2002 Kruse et al., 2002 Livshits et al., 2003 8.1 (5% Increase) Simic et al., 2002 a 1.5 (15% Increase) 3.7 (311% Increase) 6.4 (156% Increase) Simic et al., 2002 Diesveld et al., 2009 Diesveld et al., 2009 82.4 40.1 Lee et al., 2007 Lee et al., 2009 : Grown on minimal media. lysA, and the biosynthesis pathway of L-methionine was shut down by deleting metX, and the L-threonine consumption was reduced by deleting tdh and down-regulating threonine dehydratase activity through site-directed mutagenesis. Thirdly, the following modifications were performed according to the transcriptome and in silico flux analysis; (1) the promoter of ppc encoding the PEP carboxylase was replaced by a stronger promoter Ptrc to enhance its expression; (2) the iclR gene encoding the repressor of isocitrate lyase and malate synthase was knocked out to enhance the glyoxylate shunt; (3) the tdcC gene encoding the uptake-carrier was deleted to cut down L-threonine uptake; (4) genes rhtA, rhtB and rhtC were overexpressed on the same episomal vector as for the thr operon to accelerate L-threonine secretion. Fourthly, the native promoter of acs encoding acetyl-CoA synthetase was substituted with the stronger promoter Ptrc to enhance its expression. The constructed strain TH28C (pBRThrABCR3) could produce 82.4 g/L L-threonine in 50 hours’ fed-batch fermentation. The L-threonine /glucose conversion rate was 39.3%. No lactate was formed and the accumulation of acetate was 2.35 g/L (Lee et al., 2007). In 2009, Lee et al. constructed a plasmid-free L-threonine hyperproducer, MDS-205, from a reduced-genome strain E. coli MDS42. In MDS-205, the thr operon together with its native promoter was substituted with the L-threonine resistant thrArBC operon under the stronger promoter Ptac on the chromosome, and the Ptac repressorcoding gene, lacI, was deleted. The tdh gene was deleted to reduce the L-threonine consumption. The L-threonine uptake facilitator-coding genes, tdcC and sstT, were substituted with a mutant exporter gene rhtA23, which not only blocked the L-threonine uptake but also enhanced its export. E. coli MDS-205 showed robust growth and performed even better in high cell-density fermentations. It could Please cite this article as: Dong X, et al, Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of Lthreonine, Biotechnol Adv (2010), doi:10.1016/j.biotechadv.2010.07.009 X. Dong et al. / Biotechnology Advances xxx (2010) xxx–xxx produce 40.1 g/L L-threonine in 30 hours’ batch-fermentation. The L-threonine /glucose conversion rate reached 39.3% (Lee et al., 2009). 4.2. L-threonine producing strains of C. glutamicum 4.2.1. Overexpressing genes in the L-threonine biosynthesis pathway In C. glutamicum, overexpression of lysC or its L-threonine resistant allele lysCr, can only achieve high L-lysine production, but not L-threonine (Cremer et al., 1991). C. glutamicum strains carrying a lysC r on the chromosome were proven to be appropriate base strains for metabolic engineering, because adequate carbon-influx into the biosynthesis pathways of aspartic family of amino acids is the very prerequisite (Colon et al., 1995; Eikmanns et al., 1991; Reinscheid et al., 1994). Genes lysC and asd are clustered on the chromosome. Mutagenesis of lysC (S301Y) which conferred S-(2-aminoethyl)-l-cysteine-resistance on aspartate kinase was found to enhance the downstream asd expression, probably due to the accidental formation of a stronger internal promoter (Kalinowski et al., 1991). But individual overexpression of asd on an episomal vector had no effect on L-lysine production (Cremer et al., 1991). In most cases, overexpression of hom and thrB in these base strains resulted in increased L-threonine production and dramatically reduced L-lysine accumulation. Overexpression of hom or/and thrB can be effective in L-threonine production only on the basis of sufficient carbon influx to the synthesis of aspartic family of amino acids. In C. glutamicum (lysC r) strains, overexpression of the L-threonine resistant homr allele alone led to L-threonine accumulation; however, the intermediate metabolite, L-homoserine, also accumulated. Although high concentrations of L-homoserine can relieve the competitive inhibition of homoserine kinase (encoded by the downstream thrB) by L-threonine, it has been shown that proportional overexpression of homr and thrB could effectively contribute to L-threonine accumulation (Colon et al., 1995; Reinscheid et al., 1994). Nevertheless, in respect of practical operations, when the wild-type hom was overexpressed on a highcopy number plasmid, positive transformants were easy to obtain, but as for the mutant homr, the transformation was particularly difficult. The successful approach was to overexpress the homr allele moderately by using a low-copy number plasmid or integrating additional copies of the gene to the chromosome. The reason is not clear yet, but it might be that certain intermediate metabolite accumulation was toxic for cell growth (Reinscheid et al., 1994). Eikmanns et al. (1991) introduced a recombinant plasmid containing the homr-thrB operon into C. glutamicum DM368-3 (AECr, AHVr). L-threonine production doubled from 0.8 g to 1.7 g. In 1994, Reinscheid et al. integrated 3 additional copies of the homr-thrB operon into the chromosome in the L-lysine producing strain C. glutamicum MH20-22B. The constructed strain could produce 7.7 g/L L -threonine, and L -lysine production was dramatically reduced from 30.4 g/L to 8.5 g/L. However, three by-products (2.5 g/ L L-homoserine, 4.1 g/L L-isoleucine, and 2.3 g/L glycine) were also accumulated in the medium. The similar results were obtained when the homr-thrB operon was overexpressed on a low copy number plasmid in C. glutamicum MH20-22B (8.2 g/L L-threonine, 8.3 g/L L-lysine, 2.7 g/L L -homoserine, 4.5 g/L L -isoleucine, and 2.0 g/L glycine) (Reinscheid et al., 1994). In 1995, Colon et al. introduced a recombinant plasmid, on which the homr allele was expressed constitutively under its native promoter and thrB was expressed inductively under the Ptac promoter, into the L-lysine producing strain C. lactofermentum ATCC21799 (AECr). The constructed strain could produce 11.8 g/L L-threonine, and L-lysine production was reduced dramatically from 22.0 g/L to 0.8 g/L. L-homoserine was not accumulated in the medium (b 0.1 g/L), but glycine and L-isoleucine accumulated up to 4.6 g/L and 1.9 g/L, respectively (Colon et al., 1995). In 2009, Diesveld et al. constructed C. glutamicum DM1800-T by introducing a recombinant plasmid, pET-T18homr-thrB-thrE, into the L-lysine producing strain DM1800 (pyc P458S, lysC T311I). 2.5 g/L L- 9 threonine was produced in the medium originally containing 4% glucose (Diesveld et al., 2009). Overexpression of thrC only led to marginal increase in L-threonine accumulation (Eikmanns et al., 1991). 4.2.2. Reducing the L-threonine consumption In 2002, Simic et al. constructed C.glutamicum DM368-2glyA', in which the promoter of glyA was mutated to weaken the conversion of L-threonine to glycine. L-threonine production was increased to 1.3 g/L, and glycine accumulation was reduced from 0.5 g/L to 0.3 g/L in minimal media, compared with the parental strain C.glutamicum DM368-2 (lysC r, homr ) (Simic et al., 2002). To reduce the L-threonine consumption, the promoter of ilvA in DM1800-T was mutated, resulting in a new strain, DM1800-96-T, characterised by an increased L-threonine production from 2.5 g/L to 4 g/L (Diesveld et al., 2009). 4.2.3. Enhancing the L-threonine export Introduction of a recombinant plasmid containing thrE into a DM368-2glyA’ strain resulted in increase of L-threonine production from 1.3 g/L to 1.5 g/L, and decrease of the glycine accumulation. When the recombinant plasmid containing thrE was introduced into a MH20-22B-(homr-thrB)3 strain, L-threonine production increased from 5.8 g/L to 8.1 g/L with reduction in accumulation of L-lysine, glycine and L-isoleucine (Simic et al., 2002). In 2009, Diesveld et al. overexpressed the E. coli genes rhtA, rhtB, rhtC and yeaS in different C. glutamicum strains. Except for rhtB, all other genes resulted in the increased L-threonine production. The best result was obtained when rhtC gene was expressed which increased L-threonine production in C. glutamicum DM368-3 (AECr, AHVr) from 0.9 g/L to 3.7 g/L and in DM1800 (pET-T18homr-thrB-thrE) from 4 g/L to 6.4 g/L without L-homoserine accumulation (Diesveld et al., 2009). 5. Outlook 5.1. Engineering the pathway Systems biology opens up a new chapter for strain construction, that is “post genome study” (Lee et al., 2005). The approach, including transcriptomics, proteomics, metabolomics and computational modeling, etc, is more efficient and more comprehensive than the traditional “step-by-step” molecular biology. Numerous L-threonine producers have been developed using conventional breeding approaches. Though, these strains are not sufficiently productive or are deficient in other respects. “Post genome study” of these strains directly unveiled the key factors influencing L-threonine synthesis, some of which were inconceivable by conventional methods/knowledge. Combining practical experience with theoretical analysis provides a more rational basis for the selection of essential gene targets to be engineered. For example, through transcriptomic analysis, the glyoxylate shunt has been found to play a role in L-threonine synthesis (Lee et al., 2003; Lee et al., 2007), which was further confirmed by experiments (Lee et al., 2007). In E. coli this anaplerotic pathway is not turned on under aerobic conditions on glucose. Through proteomic analysis, Kim and co-workers found that the accumulation of precursor contributed significantly to the increased production of L-threonine (Kim et al., 2004), which was consistent with practice. Through in vitro modeling, Chassagnole and co-workers determined kinetic parameters and interactions between intermediates and catalyzing enzymes throughout the L-threonine biosynthesis pathway under realistic cellular conditions (Chassagnole et al., 2001), which suggested basis for predicting metabolic flux changes that may be caused by genetic manipulations. Through the analysis of an in silico kinetic model of E. coli, Rodríguez-Prados and co-workers suggested that the deletion of pyruvate kinase was sufficient to increase L-threonine production, with up-modulation of phosphotransferase system, Please cite this article as: Dong X, et al, Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of Lthreonine, Biotechnol Adv (2010), doi:10.1016/j.biotechadv.2010.07.009 10 X. Dong et al. / Biotechnology Advances xxx (2010) xxx–xxx homoserine dehydrogenase, aspartyl semialdehyde dehydrogenase and aldolase (Rodríguez-Prados et al., 2009). Nevertheless, most of such systematic information has been acquired from E. coli L-threonine producers. Thus, systems metabolic engineering has only been applied to constructing L-threonine producers of E. coli strains. On the other hand, systems biology approaches have only recently been applied to C. glutamicum because of limited availability of tools. L-lysine producing strains of C. glutamicum have been intensively analyzed and improved by utilizing post genome technologies (Krömer et al., 2004; Sindelar and Wendisch, 2007). Furthermore, L-valine hyper-producers of C. glutamicum have already been successfully developed by successive genetic manipulations (Blombach et al., 2008). Lack of strong promoters in C. glutamicum apparently hinders the development of L-threonine producers. The most widely used promoters, Ptac and Ptrc, employed in gene overexpression were shown to function efficiently in C. glutamicum (Nesvera and Pátek, 2008) but to a much weaker extent than in E. coli. Some relevant biological information has just been discovered in recent years such as identification of glyA (Simic et al., 2002), novel pathways for L-lysine (Schrumpf et al., 1991) and L-methionine (Rückert et al., 2003) synthesis branches, and regulation of TCA and glyoxylate cycles in C. glutamicum (Bott, 2007; Han et al., 2008). The glyA gene, for example, whose product mainly fulfills methyltransferation from L-serine to tetrahydrofolic acid, represents the generation of active C-1 block molecules for cellular activities and is essential for cell growth because its deficiency causes growth retardation (Wendisch et al., 2005). The reason why C. glutamicum employs both split pathways for the L-lysine and L-methionine branches remains obscure and so far no modifications aiming at limitation of the two branches, so as to increase L-threonine production, have yet been reported. Thus, to construct a genetically determined L-threonine hyper-producer of C. glutamicum, a more demanding strategy is required. 5.2. Enzymes engineering To date, the widely adopted enzyme modification schemes can be divided into two categories. One is to sequence the coding gene for a proven inhibition resistant homolog, identifying positive mutations by sequence comparison with the wild-type allele, and then only apply positive mutations to the wild-type allele to obtain a desensitized mutant. The other is to utilize bioinformatic methods to analyze sequences of the alleles from different species to roughly identify the location of the regulatory and catalytic domains according to the principle of sequence conservation, and then mutate or delete the deduced coding sequence for the regulatory domain with the expectation that the result will be a desensitized mutant. Significant achievements have been made in applying both schemes. In the future, enzymes engineering based on synthetic biology will be a more rational strategy for novel strain constructions than simply overexpressing or knocking out the coding genes (Heinemann and Panke, 2006; Picataggio, 2009). Some key enzymes in L-threonine biosynthesis pathway, such as aspartate kinase III and aspartyl semialdehyde dehydrogenase of E. coli, and aspartate kinase of C. glutamicum, have been purified and their structures analyzed (Hadfield et al., 1999; Kotaka et al., 2006; Yoshida et al., 2007). Based on the structure information, biochemical characteristics such as Km, Ki and Kcat of the key enzymes can be modified by genetic manipulation to optimize the L-threonine production. In addition, it was proposed that “substrate channeling”, a process in which the intermediate produced by one enzyme is directly transferred to the next enzyme or active site without being released into the solution (Spivey and Ovádi, 1999), might be the trigger of evolution of E. coli aspartate kinase I–homoserine dehydrogenase I and aspartate kinase II–homoserine dehydrogenase II (Fondi et al., 2007); in vitro “substrate channeling” has been developed for oxaloacetate between aspartate aminotransferase and malate dehydrogenase (Anderson, 1999), and for aspartyl-P between aspartate kinase and aspartyl semialdehyde dehydrogenase (James and Viola, 2002b), suggesting that it might be possible to construct artificial, bifunctional enzymes in vivo for high catalytic efficiency. 5.3. Improving production stability The greatest disadvantage of genetically engineered producing strains is that their productivity is unstable, usually because of the loss of recombinant plasmids (Nudel et al., 1989; Wang et al., 1999). This is especially the case with some specific genes, the overexpression of which lead to accumulation of metabolites unfavorable for cell growth (Reinscheid et al., 1994). Thus in the fermentation course of a plasmid-containing producing strain, the presence of antibiotics may be required to provide selective pressure to maintain the plasmid stability. This is obviously undesirable for industrial production and problematic for food/drug-grade L-threonine production. Without selective pressure stringent requirements for cultivation, such as a strictly defined temperature (Wang et al., 1999), may be demanded. The conventional way to solve this problem is to delete a certain nonessential gene on the chromosome, then express the same gene on the plasmid, e.g. thrC, or knock out a wild-type gene and introduce a truncated-promoter allele of the gene to increase copy-number of an insert, or reduce the flux of the downstream pathway, i.e. knockingout ilvA (Debabov, 2003). These methods have been proven to be effective for maintaining plasmid stability, due to the intrinsic need of the cells for enough L-threonine and L-isoleucine for normal propagation. These strategies are well suited to the concept of engineering physiological functionality, the importance of which has recently been reviewed (Zhang et al., 2009b). As the technologies of gene deletion and replacement have been highly developed, and promoters of different strengths have been widely studied, both in E. coli and C. glutamicum (Pátek et al., 1996), gene overexpression can now also be realized by chromosomal engineering without introducing any heterologous gene mark. Thus derepression can be achieved by promoter substitution, and disinhibition can be carried out by gene replacement with a mutant allele. Since an increase in enzyme activity is not necessarily proportional to copy number, and nor is production to enzymatic activity, plasmid-free strategies may be considered. Some successful cases have been reported. A plasmidfree L-lysine producer of C. glutamicum has been constructed by chromosomal mutation of lysC plus up-modulation of the dapA promoter (de Graaf et al., 2001). Furthermore, a plasmid-free L-valine producer of C. glutamicum has been constructed by chromosomally upand down-modulation of promoters of related genes together with gene knockout (Holátko et al., 2009), in addition to the L-threonine producer of E. coli MDS-205 (Lee et al., 2009). 5.4. Extending the substrate spectrum Extending the substrate spectrum of producing strains is industrially desirable to reduce the cost and increase production flexibility. Oligosaccharide and polysaccharide substrates are more abundant and cheaper than the directly usable monosaccharides. However, strains of different species possess different sugar uptake and metabolic systems, and are not able to utilize all kinds of sugars. As for E. coli, glucose, lactose, and succinate, etc, can be utilized as carbon and energy source, but sucrose is occasionally excluded (Bockmann et al., 1992; Jahreis et al., 2002). In the case of C. glutamicum, glucose, myo-inositol and ethanol, etc, can be utilized, but lactose is excluded (Arndt and Eikmanns, 2008; Arndt et al., 2008; Krings et al., 2006). In addition, both these species can not directly utilize polysaccharides. Genetically engineering the sugar uptake and metabolic system of the producing strains by introducing homologous or heterologous genes can confer an extended substrate spectrum on particular strains (Adham et al., 2001; Jojima et al., 2010; Jolkver et al., 2009; Rittmann Please cite this article as: Dong X, et al, Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of Lthreonine, Biotechnol Adv (2010), doi:10.1016/j.biotechadv.2010.07.009 X. Dong et al. / Biotechnology Advances xxx (2010) xxx–xxx et al., 2008). A few successful trials in this direction have been reported. An L-threonine producer of an E. coli strain which was initially unable to assimilate sucrose acquired such ability after being equipped with a sucA-sucB operon (Debabov, 2003). An L-lysine producer of C. glutamicum strain was able to utilize lactose as the carbon and energy source by introducing the heterologous lactose permease and β-galactosidase coding genes of L. delbrueckii subsp. Bulgaricus (Barrett et al., 2004). Another L-lysine producer of C. glutamicum was even able to directly utilize homopolysaccharide after transfection with the α-amylase gene, amy, of Streptomyces griseous (Seibold et al., 2006). 6. Conclusion In this review, which focused on the main L-threonine producing species, E. coli and C. glutamicum, we summarized the genetic and enzymatic information related to the L-threonine production, as well as the strategies employed in strain construction by presenting representative studies. All the above-mentioned strains are defined genetically. Although most of the genetically engineered L-threonine producers are less competitive in productivity than conventionally mutated and selected clones in which L-threonine productivity could be as high as 100 g/L in E. coli and 57.7 g/L in C. glutamicum carrying a recombinant plasmid (Ikeda, 2003), knowledge generated from these studies is of considerable significance to better understand cellular metabolism and for future strain development, especially for construction of L-threonine producers with minimum genetic alterations from the wild-type strains. At present, E. coli strains dominate as L-threonine producers, with their advantage of robust growth. As comprehensive understanding (Feist and Palsson, 2008) and discovery of new methods (Tyo et al., 2009) proceed, there is still scope for improvement of highly productive E. coli strains. Nevertheless, E. coli strains are not suitable for pharmaceutical-grade amino acid production because they synthesize endotoxins (Wang and Quinn, 2010). With the rapid development of tools applicable for C. glutamicum (Kirchner and Tauch, 2003; Xu et al., 2010), e.g. Kanamycin/SacB double selective system (Schäfer et al., 1994), Cre/loxP knockout and integration system (Suzuki et al., 2005; Suzuki et al., 2007), and even a data warehouse, CoryneRegNet, facilitating post genome study (Baumbach et al., 2006), the food-safety-grade C. glutamicum strains show considerable promise as industrial L-threonine producers. Acknowledgments This work was supported by Chinese 863 National High-Tech Research and Development Plan Project (No. 2007AA02Z229 and No. 2007AA02Z230), the 111 Project (No. 111-2-06) and the Basic Research Programs of Jiangsu Province (BK2009003). References Adham SAI, Campelo AB, Ramos A, Gil JA. Construction of a xylanase-producing strain of Brevibacterium lactofermentum by stable integration of an engineered xysa gene from Streptomyces halstedii JM8. Appl Environ Microbiol 2001:5425–30. Ajinomoto. http://www.ajinomoto.com/ir/pdf/Feed-useAA-Oct2009.pdf. Feed-use amino acids business, 2009. Almaas E, Kovács B, Vicsek T, Oltvai ZN, Barabási AL. Global organization of metabolic fluxes in the bacterium Escherichia coli. Nature 2004;427:839–43. Anderson KS. Fundamental mechanisms of substrate channeling. Methods Enzymol 1999;308:111–45. Archer J, Solow-Cordero E, Sinskey AJ. A C-terminal deletion in Corynebacterium glutamicum homoserine dehydrogenase abolishes allosteric inhibition by L-threonine. Gene 1991;107:53–9. Arndt A, Auchter M, Ishige T, Wendisch VF, Eikmanns BJ. Ethanol catabolism in Corynebacterium glutamicum. J Mol Microbiol Biotechnol 2008;15:222–33. Arndt A, Eikmanns BJ. Regulation of carbon metabolism in Corynebacterium glutamicum. In: Bukovski A, editor. Corynebacteria: genomics and molecular biology. Wymondham: Caister Academic Press; 2008. p. 155–82. 11 Barrett E, Stanton C, Zelder O, Fitzgerald G, Ross RP. Heterologous expression of lactoseand galactose-utilizing pathways from lactic acid bacteria in Corynebacterium glutamicum for production of lysine in whey. Appl Environ Microbiol 2004;70: 2861–6. Baumbach J, Brinkrolf K, Czaja LF, Rahmann S, Tauch A. CoryneRegNet: An ontologybased data warehouse of corynebacterial transcription factors and regulatory networks. BMC Genomics 2006;7:24–35. Bell SC, Turner JM. Bacterial catabolism of threonine. Threonine degradation initiated by L-threonine-NAD + oxidoreductase. Biochem J 1976;156:449–58. Blombach B, Schreiner ME, Bartek T, Oldiges M, Eikmanns BJ. Corynebacterium glutamicum tailored for high-yield L-valine production. Appl Microbiol Biotechnol 2008;79:471–9. Bockmann J, Heuel H, Lengeler JW. Characterization of a chromosomally encoded, nonPTS metabolic pathway for sucrose utilization in Escherichia coli EC3132. Mol Gen Genet 1992;235:22–32. Bott M. Offering surprises: TCA cycle regulation in Corynebacterium glutamicum. Trends Microbiol 2007;15:417–25. Boy E, Patte JC. Multivalent repression of aspartic semialdehyde dehydrogenase in Escherichia coli K-12. J Bacteriol 1972;112:84–92. Cassan M, Parsot C, Cohen GN, Patte JC. Nucleotide sequence of lysC gene encoding the lysine-sensitive aspartokinase III of Escherichia coli K12. J Biol Chem 1986;261: 1052–7. Chassagnole C, Raïs B, Quentin E, Fell DA, Mazat JP. An integrated study of threoninepathway enzyme kinetics in Escherichia coli. Biochem J 2001;356:415–23. Chipman DM, Shaanan B. The ACT domain family. Curr Opin Struc Biol 2001;11: 694–700. Cremer J, Treptow C, Eggeling L, Sahm H. Regulation of enzymes of lysine biosynthesis in Corynebacterium glutamicum. J Gen Microbiol 1988;134:3221–9. Cremer J, Eggeling L, Sahm H. Control of the lysine biosynthetic sequence in Corynebacterium glutamicum as analyzed by overexpression of the individual corresponding genes. Appl Environ Microbiol 1991;57:1746–52. Curien G, Bastien O, Robert-Genthon M, Cornish-Bowden A, Cárdenas ML, Dumas R. Understanding the regulation of aspartate metabolism using a model based on measured kinetic parameters. Mol Syst Biol 2009;5:271–84. Colon GE, Jetten MS, Nguyen TT, Gubler ME, Follettie MT, Sinskey AJ, et al. Effect of inducible thrB expression on amino acid production in Corynebacterium lactofermentum ATCC 21799. Appl Environ Microbiol 1995;61:74–8. Debabov VG. The threonine story. Adv Biochem Eng Biot 2003;79:113–36. de Graaf AA, Eggeling L, Sahm H. Metabolic engineering for L-lysine production by Corynebacterium glutamicum. Adv Biochem Eng Biot 2001;73:9-29. Diesveld R, Tietze N, Fürst O, Reth A, Bathe B, Sahm H, et al. Activity of exporters of Escherichia coli in Corynebacterium glutamicum, and their use to increase L-threonine production. J Mol Microbiol Biotechnol 2009;16:198–207. Eggeling L, Sahm H. Review: The cell wall barrier of Corynebacterium glutamicum and amino acid efflux. J Biosci Bioeng 2001;92:201–13. Eggeling L, Sahm H. New ubiquitous translocators: amino acid export by Corynebacterium glutamicum and Escherichia coli. Arch Microbiol 2003;180:155–60. Eikmanns BJ, Metzger M, Reinscheid D, Kircher M, Sahm H. Amplification of three biosynthesis genes in Corynebacterium glutamicum and its influence on carbon flux in different strains. Appl Microbiol Biotechnol 1991;34:617–22. Fazel A, Mueller K, Le Bras G, Garel JR, Veron M, Cohen GN. A triglobular model for the polypeptide chain of aspartokinase I-homoserine dehydrogenase I of Escherichia coli. Biochemistry 1983;22:158–65. Feist AM, Palsson B. The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli. Nat Biotechnol 2008;26:659–67. Follettie MT, Shin HK, Sinskey AJ. Organization and regulation of the Corynebacterium glutamicum hom-thrB and thrC loci. Mol Microbiol 1988;2:53–62. Fondi M, Brilli M, Fani R. On the origin and evolution of biosynthetic pathways: integrating microarray data with structure and organization of the common pathway genes. BMC Bioinformatics 2007;8(Suppl 1):S12. Furukawa S, Ozaki A, Nakanishi T. L-threonine production by L-aspartate- and L-homoserineresistant mutant of Escherichia coli. Appl Microbiol Biotechnol 1988;29:550–3. Gardner JF, Reznikoff WS. Identification and restriction endonuclease mapping of the threonine operon regulatory region. J Mol Biol 1978;126:241–58. Gardner JF. Regulation of the threonine operon: tandem threonine and isoleucine codons in the control region and translational control of transcription termination. Proc Natl Acad Sci U S A 1979;76:1706–10. Gruber AR, Lorenz R, Bernhart SH, Neuböck R, Hofacker IL. The Vienna RNA Websuite. Nucleic Acids Res 2008:1–5. Grundy FJ, Lehman SC, Henkin TM. The L box regulon: Lysine sensing by leader RNAs of bacterial lysine biosynthesis genes. Proc Natl Acad Sci U S A 2003;100:12057–62. Hadfield A, Kryger G, Ouyang J, Petsko GA, Ringe D, Viola R. Structure of aspartate-βsemialdehyde dehydrogenase from Escherichia coli, a key enzyme in the aspartate family of amino acid biosynthesis. J Mol Biol 1999;289:991-1002. Han SO, Inui M, Yukawa H. Transcription of Corynebacterium glutamicum genes involved in tricarboxylic acid cycle and glyoxylate cycle. J Mol Microbiol Biotechnol 2008;15:264–76. Hartman IV JL. Buffering of deoxyribonucleotide pool homeostasis by threonine metabolism. Proc Natl Acad Sci U S A 2007;104:11700–5. Heinemann M, Panke S. Synthetic biology—putting engineering into biology. Bioinformatics 2006;22:2790–9. Henkin TM, Yanofsky C. Regulation by transcription attenuation in bacteria: how RNA provides instructions for transcription termination/antitermination decisions. BioEssays 2002;24:700–7. Hofacker IL, Fontana W, Stadler PF, Bonhoeffer S, Tacker M, Schuster P. Fast folding and comparison of RNA secondary structures. Monatsh Chem 1994;125:167–88. Please cite this article as: Dong X, et al, Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of Lthreonine, Biotechnol Adv (2010), doi:10.1016/j.biotechadv.2010.07.009 12 X. Dong et al. / Biotechnology Advances xxx (2010) xxx–xxx Holátko J, Elišáková V, Prouza M, Sobotka M, Nešvera J, Pátek M. Metabolic engineering of the L-valine biosynthetic pathway in Corynebacterium glutamicum using promoter activity modulation. J Biotech 2009;139:203–10. Ikeda M. Amino acid production processes. Adv Biochem Eng Biot 2003;79:1-31. Jahreis K, Bentler L, Bockmann J, Hans S, Meyer A, Siepelmeyer J, et al. Adaptation of sucrose metabolism in the Escherichia coli wild-type strain EC3132. J Bacteriol 2002;184:5307–16. James CL, Viola RE. Production and characterization of bifunctional enzymes. Domain swapping to produce new bifunctional enzymes in the aspartate pathway. Biochemistry 2002a;41:3720–5. James CL, Viola RE. Production and characterization of bifunctional enzymes. Substrate channeling in the aspartate pathway. Biochemistry 2002;41:3726–31. Jetten MSM, Follettie MT, Sinskey AJ. Effect of different levels of aspartokinase on the lysine production by Corynebacterium lactofermentum. Appl Microbiol Biotechnol 1995;43:76–82. Jolkver E, Emer D, Ballan S, Krämer S, Eikmanns BJ, Marin K. Identification and characterization of a bacterial transport system for the uptake of pyruvate, propionate, and acetate in Corynebacterium glutamicum. J Bacteriol 2009;191:940–8. Jojima T, Omumasaba CA, Inui M, Yukawa H. Sugar transporters in efficient utilization of mixed sugar substrates: current knowledge and outlook. Appl Microbiol Biotechnol 2010;85:471–80. Kalinowski J, Bachmann B, Thierbach G, Pühler A. Aspartokinase genes lysCα and lysCβ overlap and are adjacent to the aspartate β-semialdehyde dehydrogenase gene asd in Corynebacterium glutamicum. Mol Gen Genet 1990;224:317–24. Kalinowski J, Cremer J, Bachmann B, Eggeling L, Sahm H, Pühler A. Genetic and biochemical analysis of the aspartokinase from Corynebacterium glutamicum. Mol Microbiol 1991;5:1197–204. Katinka M, Cossart P, Sibilli L, Saint-Girons I, Chalvignac MA, Le Bras G, Cohen GN, Yaniv M. Nucleotide sequence of the thrA gene of Escherichia coli. Proc Natl Acad Sci U S A 1980;77:5730–3. Kato C, Kurihara T, Kobashi N, Yamane H, Nishiyama M. Conversion of feedback regulation in aspartate kinase by domain exchange. Biochem Bioph Res Co 2004;316:802–8. Kim YH, Park JS, Cho JY, Cho KM, Park YH, Lee J. Proteomic response analysis of a threonine-overproducing mutant of Escherichia coli. Biochem J 2004;381:823–9. Kinoshita S, Nakayama K, Akita S. Taxonomical study of glutamic acid accumulating bacteria. Bull Agric Chem Soc Jpn 1958;22:176–85. Kirchner O, Tauch A. Tools for genetic engineering in the amino acid-producing bacterium Corynebacterium glutamicum. J Biotechnol 2003;104:287–99. Komatsubara S, Kisumi M, Murata K, Chibata I. Threonine production by regulatory mutants of Serratia marcescens. Appl Environ Microbiol 1978;35:834–40. Kotaka M, Ren J, Lockyer M, Hawkins AR, Stammers DK. Structures of R- and T-state Escherichia coli aspartokinase III mechanisms of the allosteric transition and inhibition by lysine. J Biol Chem 2006;281:31544–52. Krings E, Krumbach K, Bathe B, Kelle R, Wendisch VF, Sahm H, et al. Characterization of myo-inositol utilization by Corynebacterium glutamicum: the stimulon, identification of transporters, and influence on L-lysine formation. J Bacteriol 2006;188:8054–61. Krömer JO, Sorgenfrei O, Klopprogge K, Heinzle E, Wittmann C. In-depth profiling of lysine-producing Corynebacterium glutamicum by combined analysis of the transcriptome, metabolome, and fluxome. J Bacteriol 2004;186:1769–84. Kruse D, Krämer R, Eggeling L, Rieping M, Pfefferle W, Tchieu JH, et al. Influence of threonine exporters on threonine production in Escherichia coli. Appl Microbiol Biotechnol 2002;59:205–10. Lee JH, Lee DE, Lee BU, Kim HS. Global analyses of transcriptomes and proteomes of a parent strain and an L-threonine -overproducing mutant strain. J Bacteriol 2003;185:5442–51. Lee JH, Sung BH, Kim MS, Blattner FR, Yoon BH, Kim JH, et al. Metabolic engineering of a reduced-genome strain of Escherichia coli for L-threonine production. Microb Cell Fact 2009;8:2-13. Lee KH, Park JH, Kim TY, Kim YU, Lee SY. Systems metabolic engineering of Escherichia coli for L-threonine production. Mol Syst Biol 2007;3:149–56. Lee SY, Lee DY, Kim TY. Systems biotechnology for strain improvement. Trends Biotechnol 2005;23:349–58. Leuchtenberger W, Huthmacher K, Drauz K. Biotechnological production of amino acids and derivatives: current status and prospects. Appl Microbiol Biotechnol 2005;69: 1–8. Liu JQ, Dairi T, Itoh N, Kataoka M, Shimizu S, Yamada H. Gene cloning, biochemical characterization and physiological characterization of a thermostable low-specificity L-threonine aldolase from Escherichia coli. Eur J Biochem 1998;255:220–6. Livshits VA, Zakataeva NP, Aleshin VV, Vitushkina MV. Identification and characterization of the new gene rhtA involved in threonine and homoserine efflux in Escherichia coli. Res Microbiol 2003;154:123–35. Mateos LM, Pisabarro A, Pátek M, Malumbres M, Guerrero C, Eikmanns BJ, et al. Transcriptional analysis and regulatory signals of the hom-thrB cluster of Brevibacterium lactofermentum. J Bacteriol 1994;176:7362–71. Miwa K, Tsuchida T, Kurahashi O, Nakamori S, Sano K, Momose H. Construction of L -threonine overproducing strains of Escherichia coli K-12 using recombinant DNA techniques. Agric Biol Chem 1983;47:2329–34. Miyajima R, Otsuka SI, Shiio I. Regulation of aspartate family amino acid biosynthesis in Brevibactenium flavum; I. Inhibition by amino acids of the enzymes in threonine biosynthesis. J Biochem 1968;63:139–48. Miyajima R, Shiio I. Regulation of aspartate family amino acid biosynthesis in Brevibacterium flavum. III. Properties of homoserine dehydrogenase. J Biochem 1970;68:311–9. Miyajima R, Shiio I. Regulation of aspartate family amino acid biosynthesis in Brevibacterium flavum. IV. Repression of the enzymes in threonine biosynthesis. Agric Biol Chem 1971;35:424–30. Mockel B, Eggeling L, Sahm H. Functional and structural analyses of threonine dehydratase from Corynebacterium glutamicum. J Bacteriol 1992;174:8065–72. Morbach S, Sahm H, Eggeling L. L-isoleucine production with Corynebacterium glutamicum: further flux increase and limitation of export. Appl Environ Microbiol 1996;62:4345–51. Morinage Y, Takagi H, Ishida M, Miwa K, Sato T, Nakamori S, et al. Threonine production by co-existence of cloned genes coding homoserine dehydrogenase and homoserine kinase in Brevibacterium lactofermentum. Agric Biol Chem 1987;51:93-100. Nesvera J, Pátek M. Plasmids and promoters in Corynebacteria and their applications. In: Burkovski A, editor. In Corynebacteria: genomics and molecular biology. Wymondham: Caister Academic Press; 2008. p. 113–55. Nudel BC, Pueyo MG, Judewicz ND, Guilietti AM. Stability of Escherichia coli strains harboring recombinant plasmids for L-threonine production. Anton Leeuw Int J G 1989;56:273–82. Palmieri L, Berns D, Krämer R, Eikmanns M. Threonine diffusion and threonine transport in Corynebacterium glutamicum and their role in threonine production. Arch Microbiol 1996;165:48–54. Pátek M, Eikmanns BJ, Pátek J, Sahm H. Promoters from Corynebacterium glutamicum: cloning, molecular analysis and search for a consensus motif. Microbiology 1996;142:1297–309. Peoples OP, Liebl W, Bodis M, Maeng PJ, Follettie MT, Archer JA, et al. Nucleotide sequence and fine structural analysis of the Corynebacterium glutamicum hom-thrB operon. Mol Microbiol 1988;2:63–72. Picataggio S. Potential impact of synthetic biology on the development of microbial systems for the production of renewable fuels and chemicals. Curr Opin Biotech 2009;19:325–9. Reinscheid DJ, Eikmanns BJ, Sahm H. Analysis of a Corynebacterium glutamicum hom gene coding for a feedback-resistant homoserine dehydrogenase. J Bacteriol 1991;173:3228–30. Reinscheid DJ, Kronemeyer W, Eggeling L, Eikmanns BJ, Sahm H. Stable expression of hom-1–thrB in Corynebacterium glutamicum and its effects on the carbon flux to threonine and related amino acids. Appl Environ Microbiol 1994;60:126–32. Rittmann D, Lindner SN, Wendisch VF. Engineering of a glycerol utilization pathway for amino acid production by Corynebacterium glutamicum. Appl Environ Microbiol 2008:6216–22. Rodríguez-Prados JC, de Atauri P, Maury J, Ortega F, Portais JC, Chassagnole C, et al. In silico strategy to rationally engineer metabolite production: A case study for threonine in Escherichia coli. Biotechnol Bioeng 2009;103:609–20. Rückert C, Pühler A, Kalinowski J. Genome-wide analysis of the L-methionine biosynthetic pathway in Corynebacterium glutamicum by targeted gene deletion and homologous complementation. J Biotech 2003;104:213–28. Schäfer A, Tauch A, Jäger W, Kalinowski J, Thierbach G, Pühler A. Small obilizable multipurpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19: selection of defined deletions in the chromosome of Corynebacterium glutamicum. Gene 1994;145:69–73. Schrumpf B, Schwarzer A, Kalinowski J, Puhler A, Eggeling L, Sahm H. A functionally split pathway for lysine synthesis in Corynebacterium glutamicium. J Bacteriol 1991;173:4510–6. Seibold G, Auchter M, Berens S, Kalinowski J, Eikmanns BJ. Utilization of soluble starch by a recombinant Corynebacterium glutamicum strain: growth and lysine production. J Biotech 2006;124:381–91. Shiio I, Miyajima R. Concerted inhibition and its reversal by end products of aspartate kinase in Brevibacterium flavum. J Biochem 1969;64:849–59. Simic P, Sahm H, Eggeling L. L-threonine export: use of peptides to identify a new translocator from Corynebacterium glutamicum. J Bacteriol 2001;183:5317–24. Simic P, Willuhn J, Sahm H, Eggeling L. Identification of glyA (Encoding serine hydroxymethyl transferase) and its use together with the exporter ThrE To increase L-threonine accumulation by Corynebacterium glutamicum. Appl Environ Microbiol 2002;68:3321–7. Sindelar G, Wendisch VF. Improving lysine production by Corynebacterium glutamicum through DNA microarray-based identification of novel target genes. Appl Microbiol Biotechnol 2007;76:677–89. Spivey HO, Ovádi J. Substrate channeling. Methods 1999;19:306–21. Suzuki N, Nonaka H, Tsuge Y, Inui M, Yukawa H. New multiple-deletion method for the Corynebacterium glutamicum genome, using a mutant lox sequence. Appl Environ Microbiol 2005;71:8472–80. Suzuki N, Inui M, Yukawa H. Site-directed integration system using a combination of mutant lox sites for Corynebacterium glutamicum. Appl Microbiol Biotechnol 2007;77:871–8. Theze J, Saint-Girons I. Threonine locus of Escherichia coli K-12: genetic structure and evidence for an operon. J Bacteriol 1974;118:990–8. Truffa-Bachi P, Veron M, Cohen GN. Structure, function, and possible origin of a bifunctional allosteric enzyme, Escherichia coli aspartokinase I–homoserine dehydrogenase I. Crit Rev Biochem Mol Biol 1974;2:379–415. Tyo KEJ, Ajikumar PK, Stephanopoulos G. Stabilized gene duplication enables longterm selection-free heterologous pathway expression. Nat Biotechnol 2009;27: 760–7. Umbarger HE, Brown B. Threonine deamination in Escherichia coli. II. Evidence for two L-threonine deaminases. J. Bacteriol 1957;73:105–12. Umbarger HE. Threonine deaminase. Adv Enzymol 1973;37:349–95. Viola RE. The central enzymes of the aspartate family of amino acid biosynthesis. Acc Chem Res 2001;34:339–49. Wang MD, Bradshaw JS, Swisher SL, Liaw HJ, Hanke PD, Binder TP. Strains of Escherichia coli, methods of preparing the same and use thereof in fermentation processes for L-threonine production. 1999. US Patent 5,939,307. Please cite this article as: Dong X, et al, Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of Lthreonine, Biotechnol Adv (2010), doi:10.1016/j.biotechadv.2010.07.009 X. Dong et al. / Biotechnology Advances xxx (2010) xxx–xxx Wang X, Quinn PJ. Lipopolysaccharide: Biosynthetic pathway and structure modification. Prog Lipid Res 2010;49:97-107. Wendisch P, Stolz M, Etterich H, Kennerknecht N, Sahm H, Eggeling L. Metabolic Engineering of Corynebacterium glutamicum for L-Serine Production. Appl Environ Microbiol 2005;71:7139–44. Xu DQ, Tan YZ, Huan XJ, Hu XQ, Wang X. Construction of a novel shuttle vector for use in Brevibacterium flavum, an industrial amino acid producer. J Microbiol Meth 2010;80:86–92. 13 Yoshida A, Tomita T, Kurihara T, Fushinobu S, Kuzuyama T, Nishiyama M. Structural insight into concerted inhibition of α2β2-type aspartate kinase from Corynebacterium glutamicum. J Mol Biol 2007;368:521–36. Zhang X, Yan JA, Yu L, Zhang GQ, Zhang Y, Chen N, et al. Construction of recombinant plasmids containing threonine operon and their effects on L-threonine accumulation. Acta Microbiologica Sinica 2009a;49:591–6. Zhang YP, Zhu Y, Zhu Y, Li Y. The importance of engineering physiological functionality into microbes. Trends Biotechnol 2009b;27:664–72. Please cite this article as: Dong X, et al, Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for the production of Lthreonine, Biotechnol Adv (2010), doi:10.1016/j.biotechadv.2010.07.009